Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap221.99M
Enterprise Value134.67M
Trailing P/E21.17
Forward P/E25.42
UTMD
(NASDAQ)Utah Medical Products, Inc.
$69.72-- (--)
Loading... - Market loading
Utah Medical Products (UTMD) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)6.15
Forward Price/Sales6.61
Price/Book (mrq)1.84
Price/Tangible Book (mrq)2.09
Price/FCF (ttm)17.05
Price/OCF (ttm)16.64
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.73
EV/Earnings12.84
EV/EBITDA9.79
EV/EBIT12.58
EV/FCF10.34
Stock Price
Current price, 52-week range, and moving averages
Current Price$69.72
1-Day Change0.81%
52-Week High$75.75
52-Week Low$53.66
52-Week Change11.02%
YTD Change23.40%
1-Year Change14.71%
50-Day MA$70.49
200-Day MA$64.98
Avg Volume (30 day)31.75K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding3.18M
Book Value per Share$37.81
Net Cash per Share$27.42
FCF per Share$4.09
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin56.43%
EBITDA Margin (ttm)38.08%
EBIT Margin (ttm)29.65%
Operating Margin (ttm)28.43%
Pretax Margin (ttm)35.68%
Profit Margin (ttm)29.04%
FCF Margin (ttm)36.06%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)8.71%
Return on Assets (ttm)8.42%
Return on Invested Capital (ttm)26.36%
Return on Capital Employed (ttm)8.74%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue36.11M
Gross Profit20.38M
Operating Income10.27M
Pretax Income12.88M
Net Income10.49M
EBITDA13.75M
EBIT10.71M
Diluted EPS$3.28
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow13.34M
Capital Expenditures317.00K
Free Cash Flow13.02M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth-7.00%
Dividend Growth1.65%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)124.57M
Cash & Securities (mrq)87.53M
Net Cash (mrq)87.32M
Net Cash per Share$27.42
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)210.00K
Working Capital (mrq)98.57M
Total Equity (mrq)120.37M
Book Value per Share$37.81
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)48.62
Quick Ratio (mrq)44.27
Debt/Equity (mrq)0.00
Debt/EBITDA (ttm)0.02
Debt/FCF (ttm)0.02
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$1.24
Dividend Yield1.77%
Payout Ratio (Earnings)37.62%
Payout Ratio (FCF)30.20%
Dividend Growth (YoY)1.65%
Years of Dividend Growth3
Ex-Dividend DateSep 17, 2026
Pay DateOct 5, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield4.72%
FCF Yield5.87%
Buyback Yield2.37%
Total Shareholder Yield4.14%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score40.67
Piotroski F-Score6/9
Dividend Score60.09
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$52.85
Graham Upside/Downside-24.20%
Frequently Asked Questions About Utah Medical Products Statistics
What are the key financial metrics for UTMD?
Utah Medical Products, Inc. (UTMD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is UTMD's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Utah Medical Products is overvalued or undervalued.
How do I read UTMD's profitability ratios?
Utah Medical Products's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do UTMD's debt ratios indicate?
The financial health section shows Utah Medical Products's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is UTMD's dividend analysis?
The dividend section covers Utah Medical Products's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.